Publicaciones en colaboración con investigadores/as de University of Washington (7)

2018

  1. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48

2012

  1. Basal insulin and cardiovascular and other outcomes in dysglycemia

    New England Journal of Medicine, Vol. 367, Núm. 4, pp. 319-328

  2. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    New England Journal of Medicine, Vol. 366, Núm. 5, pp. 433-442

  3. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

    New England Journal of Medicine, Vol. 367, Núm. 4, pp. 309-318

2010

  1. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  2. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

2007

  1. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis

    Tissue Antigens, Vol. 70, Núm. 2, pp. 110-127